Dr. Reddy’s Laboratories Ltd. expects its generic anti-obesity drug to shore up growth in the six months through March after it resolves an impurity issue with the key ingredient and resumes supply in early November.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-07-30/dr-reddy-s-sees-weight-loss-drug-boosting-growth-after-setback)